Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Central Line Associated Blood Stream Infections (CLABSI): later-stage trial registry
2 of 2 indexed Central Line Associated Blood Stream Infections (CLABSI) trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Central Line Associated Blood Stream Infections (CLABSI): 2 US clinical trials tracked, 2 recruiting.
Central Line Associated Blood Stream Infections (CLABSI) is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is CorMedix, running 1 of these trials.
Enrollment posture brief
Registry condition central-line-associated-blood-stream-infections-clabsi
OPEN 2 | RECR 100% | LATE 1 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Central Line Associated Blood Stream Infections (CLABSI) lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Central Line Associated Blood Stream Infections (CLABSI) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Central Line Associated Blood Stream Infections (CLABSI) is recruiting above its size-band peers.
2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
Swedish Medical Center
NCT07108660
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
CorMedix
NCT06822426
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Central Line Associated Blood Stream Infections (CLABSI) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Central Line Associated Blood Stream Infections (CLABSI) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Central Line Associated Blood Stream Infections (CLABSI) page
2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Central Line Associated Blood Stream Infections (CLABSI) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- CorMedix sponsors the most Central Line Associated Blood Stream Infections (CLABSI) trials on record, review their full trial history before evaluating a specific study. See CorMedix's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Central Line Associated Blood Stream Infections (CLABSI) condition card totals 2 registered trials; most-linked intervention (taurolidine and heparin) catheter lock solution; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.